Article citationsMore>>

Armah, G., Pringle, K., Enweronu-Laryea, C.C., Ansong, D., Mwenda, J.M., Diamenu, S.K., Narh, C., Lartey, B., Binka, F., Grytdal, S., Patel, M., Parashar, U. and Lopman, B. (2016) Impact and Effectiveness of Monovalent Rotavirus Vaccine against Severe Rotavirus Diarrhea in Ghana. Clinical Infectious Diseases, 62, S200-207. https://doi.org/10.1093/cid/ciw014

has been cited by the following article:

• TITLE: Evaluation of Adverse Events Following Immunization against Rotavirus Regardless of Recommended Age Restriction

  AUTHORS: Jesus Reyna-Figueroa, Irina Jeanette Bercholc-Urinowsky, Gabriela Cardoso-Yah, Ricardo Platón Vazquez-Alvarado, Dalila Ramos-López, Freya Helena Campos-Romero, Cory Handelsman, Ana Elena Limón-Rojas

  KEYWORDS: Rotavirus, Vaccination, Age Restriction, Adverse Reaction

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.5 No.8, August 17, 2017

  ABSTRACT: Introduction: Mild and moderate Adverse Events Following Immunization (AEFI) against Rotavirus has not received much attention when the vaccine is administered regardless of recommended age restriction. Objectives: To describe the behavior of mild and moderate AEFI in immunized subjects against Rotavirus, in who age restriction period had not been considered. Methods: A case-control study in which we included immunized patients with monovalent oral vaccine against rotavirus and divided them into two groups: 1) Infants who received RV1 vaccine without considering the recommended period, and 2) Infants who were vaccinated with the recommended schedule. Results: From the total doses, 143/1894 (7.5%) were administered outside the restriction period. The most frequent AEFIs with the first dose were purpura, polypnea, and rhinorrhea; For the second dose: purpura, bloody stools, irritability and rhinorrhea. Conclusions: This study shows the benefits from vaccination regardless of age restriction are more beneficial compared to the possible risks of AEFI.